Certain carcinogens are thought to induce renal and bladder cancer following metabolic activation. We propose a model system for this activation and provide supporting experimental evidence. This model proposes that renal and bladder carcinogens' entry into the urinary tract is facilitated, that carcinogens are activated by the prostaglandin hydroperoxidase activity of prostaglandin endoperoxide synthetase (PES), and that activation results in covalent binding to nucleic acids which can initiate carcinogenesis. Benzidine and the 5-nitrofuran HMN were shown to inhibit uptake of organic anions and cations, respectively. Carcinogen binding to DNA was dependent upon specific unsaturated fatty acid substrates and prevented by specific inhibitors of PES, i.e., aspirin. Activation with organic peroxides or H202 was inhibited by antioxidants but not aspirin. Horseradish peroxidase (HRP) metabolized benzidine but not ANFT. Acetaminophen and the 5-nitrofurans ANFT and HMN prevented PES '4C-benzidine metabolism. However, only acetaminophen inhibited HRP metabolism of benzidine. The only aerobic metabolism we have observed of 5-nitrofurans is PES-catalyzed. Aspirin (0.5% in the diet) inhibited rat bladder hyperplastic lesions induced by feeding 0.1% or 0.2% FANFT for 6 or 12 weeks. Aspirin reduced bladder prostaglandin synthesis and PES metabolism of FANFT. After one year of an ongoing long-term study, gross examination reveals bladder tumors in 85% of the rats fed 0.2% FANFT and in only 37% of the rats fed FANFT plus 0.5% aspirin.
Introduction
We have developed an experimental model to explain the initiation by certain chemicals of renal and bladder cancer. This model is based on the hypothesis that these urinary tract carcinogens are activated by the hydroperoxidase activity of prostaglandin endoperoxide synthetase (PES). Activation results in initiation of the carcinogenic process. We have used the 5-nitrofuran carcinogens 2-amino-4-(5 nitro-2-furyl-thiazole (ANFT) and N-[445-nitro-2-furyl-2-thiazolyl] formamide (FANFT) and the aromatic amine benzidine to develop this model. In particular, advantage was taken of a well-defined rat model in which urinary bladder cancer is induced with FANFT (1) . We will present the experimental evidence which supports our model and examine the possible involvement of other peroxidases in the initiation of urinary tract carcinogenesis. 
Characteristics of Prostaglandin Endoperoxide Synthetase
Purified PES enzyme ( Fig. 1) has been shown to consist of two separate activities: fatty acid cyclooxygenase and prostaglandin hydroperoxidase (2) . Fatty acid cyclooxygenase is responsible for the initial bisdioxygenation of the unsaturated fatty acid. For arachidonic acid, this product is prostaglandin G,, a 15-hydroperoxy prostaglandin cyclic endoperoxide. The hydroperoxidase activity is responsible for cleavage of the 15-hydroperoxy group. With prostaglandin G2 as substrate, the product is the 15-hydroxy cyclic endoperoxide prostaglandin H2. Prostaglandin H2 is the common substrate for synthesis of prostaglandins and thromboxanes. PES has been shown to exist as a dimer with each individual subunit having a molecular weight of 72,000 (3) . Certain (6) . PES has been shown to be uniquely distributed within the kidney (7) with the most activity in the renal medulla (8) .
Immunohistofluorescence studies which localize PES subcellularly have demonstrated that the enzyme system is associated with the endoplasmic reticulum and nuclear membrane (9) . The hydroperoxidase activity of PES is responsible for the cooxidative metabolism of carcinogens. Cooxidative metabolism has been demonstrated with microsomes, intact tissue slices and in vivo. Major classes of compounds metabolized by PES include aromatic amines (10), aromatic amides (11), 5- nitrofurans (10) , and polycyclic aromatic hydrocarbons (12) . Cooxidative metabolism of 7,8-dihydroxy-7,8-dihydrobenzo(a)pyrene (12) and the aromatic amines benzidine and 2-naphthylamine (13) has been shown to result in the formation of mutagens.
Metabolism and Activation of Benzidine and 5*Nitrofurans by Microsomal Prostaglandin Endoperoxide Synthetase
Benzidine and the 5-nitrofuran urinary tract carcinogens are not thought to be proximal carcinogens because they initiate carcinogenesis at a site distant from their entry into the body. Therefore, these carcinogens require activation to elicit their carcinogenic effects. Using '4C-ANFT and bladder epithelial microsomes (14) , PES-catalyzed activation was assessed by covalent binding to protein and DNA ( (15) . These results are consistent with PES playing a role in 5-nitrofuran and benzidine-induced renal and bladder carcinogenesis. The dose-response effect of indomethacin on renal inner medullary microsomal synthesis of PGE2 and cooxidation of '4C-benzidine was used to assess the relationship between renal prostaglandin synthesis and cooxidation (Fig. 2) . Two separate incubation conditions were used to assess these effects (16) . 
Demonstration of Intact Tissue Metabolism of 14C-Benzidine by Prostaglandin Endoperoxide Synthetase
If PES-catalyzed metabolism of urinary tract carcinogens is an important step in initiation of the carcinogenic process, this metabolism should be demonstrable with intact tissue. 14C-Benzidine metabolism by renal medullary tissue slices was used as a test system (Fig. 3 ). Slices were subjected to two successive incubations with Krebs-Ringer bicarbonate buffer containing 1 mg/mL each of glucose and BSA (18) . Both 0.15 mM arachidonic acid and 25 ,.M 14C-benzidine were present in only the final incubation. Other test agents were present in both incubations. Metabolism was assessed by binding to TCA-precipitable material. Benzidine metabolism was indicated by an increase in radioactivity over the blank which contained heated tissue slices or slices incubated anaerobically. 14C-Benzidine binding was increased by arachidonic acid. While inhibitors of PES prevented this increase, SKF-525A and metyrapone, inhibitors of mixed-function oxidases, were not effective. These results are consistent with an experiment demonstrating in vivo PES-catalyzed metabolism of "4C-benzidine by dog kidney (19) . 14C-Benzidine was administered by retrograde perfusions into the renal pelvis through a ureteral catheter. Benzidine metabolism in subsequent urinary collections was prevented by meclofenamic acid. These results are consistent with microsomal, intact tissue and in vivo metabolism of urinary tract carcinogens by PES.
Role of Peroxidases in Chemical Carcinogenesis
Hemeprotein peroxidases are present in mammalian tissues and catalyze metabolic activation of carcinogens. Both Forrester (20) and Bartsch (21) The catalysis of 14C-benzidine and 14C-ANFT binding to TCA-precipitable material was examined with ram seminal vesicle PES and horseradish peroxidase. Binding was indicated by an increase in radioactivity over blank values obtained with samples containing 2 mg/mL bovine serum albumin but not enzyme. Both PES and horseradish peroxidase metabolized benzidine (Table 2 ). Arachidonic acid-but not HPETE-mediated metabolism-was prevented by aspirin. The lack of effect of salicylate, the deacetylated metabolite of aspirin, suggests that aspirin inhibition is due to acetylation of the fatty acid cyclooxygenase component of PES. At 0.2 mM KCN, horseradish peroxidase but not PES-catalyzed metabolism was inhibited. The antioxidant vitamin E prevented binding of "4C-benzidine catalyzed by both peroxidases. Both peroxidases catalyze binding of benzidine to DNA as well as protein (not shown).
To further assess the specificity of the peroxidase enzymes, metabolism of ANFT was determined (Table 3) . PES catalyzed binding of ANFT but horseradish peroxidase did not. As previously shown, ANFT binding was consistent with metabolism by prostaglandin hydroperoxidase component of PES. PES-catalyzed binding of 14C-ANFT to DNA has been demonstrated ( Table 1) .
The mechanism of benzidine metabolism by horseradish peroxidase and prostaglandin endoperoxide synthetase was further investigated using electron paramagnetic resonance. As shown in A model describing the relationship of PES and other peroxidases in the activation of carcinogens is illustrated in Figure 6 . This model is consistent with the results above. Three types of peroxidatic reactions are envisioned. Type 1 reactions occur with carcinogens that are metabolized only by the hydroperoxidase component of PES. PES-catalyzed activation of 5-nitrofurans is a type 1 reaction. Type 2 reactions occur with carcinogens that are metabolized by both prostaglandin hydroperoxidase and other peroxidases. Aromatic amines and diethylstilbestrol activation appears to occur by a type 2 reaction. In contrast to the other peroxidases, prostaglandin hydroperoxidase is part of a complex which generates its own hydroperoxide substrate, prostaglandin G2. Type 3 reactions would occur with certain carcinogens which are metabolized by other peroxidases and not PES. There is not a known type 3 reaction at this time. This model suggests a more expanded role is very important in the carcinogenic process. Organic acid and base transport by renal cortical slices were investigated by using "3'I-hippuran and '4C-tetraethylammonium, respectively (Table 4) . Since both transport systems are energy dependent, their dramatic inhibition by anaerobic incubation conditions suggests that they are valid model systems (29) . The 5-nitrofuran 3-hydroxymethyl-1-[(3-(5-nitro-2-furyl-allydidene)amino]-hydantoin (HMN) inhibited organic acid but not base transport. HMN inhibition of organic acid transport was shown to be dose dependent and reversible (not shown). This suggests that the 5-nitro group of HMN functions as a carboxylate anion. Benzidine inhibited organic base but not acid transport. These results are consistent with transport of 5-nitrofurans and aromatic amines by organic acid and base transport systems, respectively, in the renal cortex. In addition to transport by the organic ion systems, drugs and xenobiotics are concentrated in urine by water reabsorption. Under physiological conditions, greater than 98% of the glomerular filtrate is removed from the lumen of the renal tubule (water reabsorption). Therefore, substrates which are not reabsorbed by the tubule will reach high concentrations in the urinary space (30) . These specific transport and concentrating properties of the kidney are further emphasized in view of the fact that the kidney receives 20-25% of the cardiac output at rest. bHyperplasia was assessed by light microscopy, and the other lesions were assessed by scanning electron microscopy. ctwo rats from each of groups 5 and 6 were killed 24 weeks after the beginning of the experiment; the other rats from these groups were killed after 12 fed FANFT plus aspirin (p < 0.004). In addition, nine rats fed FANFT plus aspirin developed forestomach tumors whereas none developed in rats fed FANFT without aspirin. Of the rats with forestomach tumors, only three also had a bladder tumor. The microscopic evaluation of these tissues is in progress.
Description of a Model System for Initiation of 5-Nitrofuran-lnduced Bladder Carcinogenesis A scheme describing the initiation of 5-nitrofuraninduced bladder carcinogenesis is shown in Figure  7 . Target tissue metabolism is a salient feature of this model. Bladder carcinogens are thought to enter the kidney by facilitated transport and/or to be concentrated by water reabsorption. The latter may partially explain why these 5-nitrofurans cause tumors in bladder but not liver. Carcinogens are activated by the hydroperoxidase activity of PES to electrophiles which covalently bind to macromolecules such as DNA. This results in the initiation of the carcinogenic process. We have experimental evidence to support each step in this model: (1) organic acid transport of 5-nitrofurans (29) ; (2) prostaglandin hydroperoxidase-catalyzed covalent binding of carcinogens to tissue macromolecules (14) ; and (3) prevention of the expression of FANFT-induced lesions by aspirin in rat feeding studies (31).
